Found: 55
Select item for more details and to access through your institution.
Breast Cancer With a HER2 FISH Group 2 Result: Should HER.2 Tests be Repeated?
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 4, p. 415, doi. 10.1016/j.clbc.2023.02.006
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01473-2
- By:
- Publication type:
- Article
A Development of Context-Appropriate Framework for Implementing Technology-Enhanced Language Learning.
- Published in:
- Multimedia-Assisted Language Learning, 2022, v. 25, n. 3, p. 61, doi. 10.15702/mall.2022.25.3.61
- By:
- Publication type:
- Article
Targeting Apoptosis in Cancer.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 3, p. 273, doi. 10.1007/s11912-022-01199-y
- By:
- Publication type:
- Article
Current challenges of metastatic breast cancer.
- Published in:
- Cancer & Metastasis Reviews, 2016, v. 35, n. 4, p. 495, doi. 10.1007/s10555-016-9636-y
- By:
- Publication type:
- Article
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 2, p. 253, doi. 10.1007/s10549-022-06572-w
- By:
- Publication type:
- Article
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 2, p. 339, doi. 10.1007/s10549-019-05166-3
- By:
- Publication type:
- Article
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 501, doi. 10.1007/s10549-018-4853-4
- By:
- Publication type:
- Article
Protective Role of Glucagon-like Peptide-1 Against Glucosamine-induced Cytotoxicity in Pancreatic Beta Cells.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2010, v. 25, n. 2/3, p. 211, doi. 10.1159/000276555
- By:
- Publication type:
- Article
A Randomized Controlled Trial of the Korean Version of the Program for the Education and Enrichment of Relational Skills for Young Adults (PEERS®-YA-K) With Autism Spectrum Disorder: A Pilot Study.
- Published in:
- Frontiers in Psychiatry, 2021, v. 12, p. 1, doi. 10.3389/fpsyt.2021.730448
- By:
- Publication type:
- Article
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231189422
- By:
- Publication type:
- Article
Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221112698
- By:
- Publication type:
- Article
ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8610, doi. 10.1245/s10434-021-10148-1
- By:
- Publication type:
- Article
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 8, p. 4265, doi. 10.1245/s10434-020-09392-8
- By:
- Publication type:
- Article
Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 12, p. 4603, doi. 10.1245/s10434-020-08891-y
- By:
- Publication type:
- Article
Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 2, p. 392, doi. 10.1245/s10434-014-4054-2
- By:
- Publication type:
- Article
Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0289627
- By:
- Publication type:
- Article
Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 391, doi. 10.1007/s10637-023-01357-4
- By:
- Publication type:
- Article
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 509, doi. 10.1007/s10637-020-00995-2
- By:
- Publication type:
- Article
Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy.
- Published in:
- European Journal of Breast Health, 2021, v. 17, n. 2, p. 128, doi. 10.4274/ejbh.galenos.2021.2021-2-9
- By:
- Publication type:
- Article
Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00440-y
- By:
- Publication type:
- Article
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3275, doi. 10.3390/cancers15133275
- By:
- Publication type:
- Article
Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1616, doi. 10.3390/cancers15051616
- By:
- Publication type:
- Article
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1323, doi. 10.3390/cancers14051323
- By:
- Publication type:
- Article
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3105, doi. 10.3390/cancers12113105
- By:
- Publication type:
- Article
Targeting Signaling Pathways in Inflammatory Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2479, doi. 10.3390/cancers12092479
- By:
- Publication type:
- Article
Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1087, doi. 10.3390/cancers11081087
- By:
- Publication type:
- Article
Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 714, doi. 10.3390/cancers11050714
- By:
- Publication type:
- Article
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0250057
- By:
- Publication type:
- Article
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241775
- By:
- Publication type:
- Article
Thrombocytosis as a prognostic factor in inflammatory breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 3, p. 819, doi. 10.1007/s10549-017-4463-6
- By:
- Publication type:
- Article
Identification of frequent somatic mutations in inflammatory breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 2, p. 263, doi. 10.1007/s10549-017-4165-0
- By:
- Publication type:
- Article
Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 3, p. 615, doi. 10.1007/s10549-014-2983-x
- By:
- Publication type:
- Article
Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 3, p. 1025, doi. 10.1002/cam4.2780
- By:
- Publication type:
- Article
Novel therapeutic strategies in the treatment of triple-negative breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 7, p. 493, doi. 10.1177/1758834017711380
- By:
- Publication type:
- Article
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231953
- By:
- Publication type:
- Article
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Design of PCR assays to specifically detect and identify 37 Lactobacillus species in a single 96 well plate.
- Published in:
- BMC Microbiology, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12866-020-01781-z
- By:
- Publication type:
- Article
SMAC Mimetic/IAP Inhibitor Birinapant Enhances Radiosensitivity of Glioblastoma Multiforme.
- Published in:
- Radiation Research, 2021, v. 195, n. 6, p. 549, doi. 10.1667/RADE-20-00171.1
- By:
- Publication type:
- Article
ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1410, doi. 10.3390/biomedicines9101410
- By:
- Publication type:
- Article
PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening.
- Published in:
- Biomedicines, 2021, v. 9, n. 7, p. 740, doi. 10.3390/biomedicines9070740
- By:
- Publication type:
- Article
Predicting Response to EGFR-Targeting mAbs in Colorectal Cancer - Is the KRAS Mutation Test Sufficient?
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 8, p. 430
- By:
- Publication type:
- Article
Utility‐based Bayesian personalized treatment selection for advanced breast cancer.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2022, v. 71, n. 5, p. 1605, doi. 10.1111/rssc.12582
- By:
- Publication type:
- Article
Development of CNS metastases and survival in patients with inflammatory breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2‐Negative Breast Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. e230, doi. 10.1002/onco.13581
- By:
- Publication type:
- Article